| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |